FDAnews Device Daily Bulletin

Endologix Receives CE Mark for Nellix EndoVascular Aneurysm Sealing System

Oct. 2, 2017

Endologix received a CE Mark for its Nellix EndoVascular aneurysm sealing system with refined indications for use.

The Company’s notified body and an independent clinical reviewer determined in a review that Nellix, with refined indications for use, meets the applicable safety and clinical performance requirements.

Nellix is also being studied in the U.S. under an Investigational Device Exemption.

View today's stories